{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:44:04Z","timestamp":1782395044900,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chugai Pharma Germany GmbH","award":["ID 16 Klinik Publikationsvertrag Version 4.0"],"award-info":[{"award-number":["ID 16 Klinik Publikationsvertrag Version 4.0"]}]},{"DOI":"10.13039\/501100005626","name":"Universit\u00e4t Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005626","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fatigue is a common symptom in patients with rheumatoid arthritis (RA) and in patients with cancer (CA). The aim was to investigate the degree of fatigue in RA patients as compared to CA patients as well as potential influencing factors on RA-related fatigue. This was a retrospective analyses of two prospective cohort studies that used the EORTC QLQ-FA12 as a common instrument to assess fatigue. The cohort of RA patients was based on a nationwide survey in Germany. The cohort of CA patients was recruited in the context of an international validation field study. Multivariable ANCOVAs compared levels of fatigue between the two cohorts, also including various subgroup analyses. Regression analyses explored influencing factors on RA patients\u2019 fatigue. Data of <jats:italic>n<\/jats:italic>\u2009=\u2009705 RA patients and of <jats:italic>n<\/jats:italic>\u2009=\u2009943 CA patients were available for analyses. RA patients reported significantly higher Physical Fatigue (mean difference\u2009=\u20097.0, 95% CI\u20094.2\u20139.7, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and Social Sequelae (mean difference\u2009=\u20097.5, 95% CI\u20094.7\u201310.2, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). CA patients reported higher Cognitive Fatigue (mean difference\u2009=\u20093.5, 95% CI\u20091.4\u20135.6, <jats:italic>p<\/jats:italic>\u2009=\u20090.001). No differences in Emotional Fatigue (<jats:italic>p<\/jats:italic>\u2009=\u20090.678) and Interference with Daily Life (<jats:italic>p<\/jats:italic>\u2009=\u20090.098) were found. In RA patients, mental health and pain were associated with fatigue (<jats:italic>p<\/jats:italic> values\u2009&lt;\u20090.001). RA patients showed a considerable level of fatigue that is comparable to and in certain cases even higher than that of CA patients. The implementation of standardized diagnostic procedures and interventions to reduce fatigue in RA patients are recommended.<\/jats:p>","DOI":"10.1007\/s00296-021-04948-7","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T21:02:55Z","timestamp":1626469375000},"page":"329-339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Self-reported fatigue in patients with rheumatoid arthritis compared to patients with cancer: results from two large-scale studies"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5241-2945","authenticated-orcid":false,"given":"Karolina","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens G.","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Pukrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens U.","family":"R\u00fcffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5252-6010","authenticated-orcid":false,"given":"Michael","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"4948_CR1","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.jpainsymman.2019.12.358","volume":"59","author":"RB Jaime-Lara","year":"2020","unstructured":"Jaime-Lara RB, Koons BC, Matura LA et al (2020) A qualitative metasynthesis of the experience of fatigue across five chronic conditions. J Pain Symptom Manag 59:1320\u20131343. https:\/\/doi.org\/10.1016\/j.jpainsymman.2019.12.358","journal-title":"J Pain Symptom Manag"},{"key":"4948_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/BOR.0000000000000376","volume":"29","author":"P Katz","year":"2017","unstructured":"Katz P (2017) Causes and consequences of fatigue in rheumatoid arthritis. Curr Opin Rheumatol 29:269\u2013276. https:\/\/doi.org\/10.1097\/BOR.0000000000000376","journal-title":"Curr Opin Rheumatol"},{"key":"4948_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.5152\/eurjrheum.2015.0029","volume":"2","author":"SC Sand\u0131k\u00e7\u0131","year":"2015","unstructured":"Sand\u0131k\u00e7\u0131 SC, \u00d6zbalkan Z (2015) Fatigue in rheumatic diseases. Eur J Rheumatol 2:109\u2013113. https:\/\/doi.org\/10.5152\/eurjrheum.2015.0029","journal-title":"Eur J Rheumatol"},{"key":"4948_CR4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/rheumatology\/kel021","volume":"45","author":"LC Pollard","year":"2006","unstructured":"Pollard LC, Choy EH, Gonzalez J et al (2006) Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford) 45:885\u2013889. https:\/\/doi.org\/10.1093\/rheumatology\/kel021","journal-title":"Rheumatology (Oxford)"},{"key":"4948_CR5","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/rheumatology\/kez314","volume":"58","author":"EH Choy","year":"2019","unstructured":"Choy EH, Dures E (2019) Fatigue in rheumatoid arthritis. Rheumatology (Oxford) 58:v1\u2013v2. https:\/\/doi.org\/10.1093\/rheumatology\/kez314","journal-title":"Rheumatology (Oxford)"},{"key":"4948_CR6","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/rheumatology\/keq282","volume":"50","author":"S Hewlett","year":"2011","unstructured":"Hewlett S, Chalder T, Choy E et al (2011) Fatigue in rheumatoid arthritis: time for a conceptual model. Rheumatology (Oxford) 50:1004\u20131006. https:\/\/doi.org\/10.1093\/rheumatology\/keq282","journal-title":"Rheumatology (Oxford)"},{"key":"4948_CR7","first-page":"1174","volume":"34","author":"JR Kirwan","year":"2007","unstructured":"Kirwan JR, Minnock P, Adebajo A et al (2007) Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J Rheumatol 34:1174\u20131177","journal-title":"J Rheumatol"},{"key":"4948_CR8","doi-asserted-by":"publisher","first-page":"v51","DOI":"10.1093\/rheumatology\/kez389","volume":"58","author":"EH Choy","year":"2019","unstructured":"Choy EH (2019) Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis. Rheumatology (Oxford) 58:v51\u2013v55. https:\/\/doi.org\/10.1093\/rheumatology\/kez389","journal-title":"Rheumatology (Oxford)"},{"key":"4948_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/annrheumdis-2018-214469","volume":"78","author":"S Hewlett","year":"2019","unstructured":"Hewlett S, Almeida C, Ambler N et al (2019) Reducing arthritis fatigue impact: two-year randomised controlled trial of cognitive behavioural approaches by rheumatology teams (RAFT). Ann Rheum Dis 78:465\u2013472. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214469","journal-title":"Ann Rheum Dis"},{"key":"4948_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11926-015-0501-8","volume":"17","author":"A-M Orbai","year":"2015","unstructured":"Orbai A-M, Bingham CO (2015) Patient reported outcomes in rheumatoid arthritis clinical trials. Curr Rheumatol Rep 17:28. https:\/\/doi.org\/10.1007\/s11926-015-0501-8","journal-title":"Curr Rheumatol Rep"},{"key":"4948_CR11","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.3899\/jrheum.141169","volume":"42","author":"SJ Bartlett","year":"2015","unstructured":"Bartlett SJ, Bykerk VP, Cooksey R et al (2015) Feasibility and domain validation of rheumatoid arthritis (RA) flare core domain set: report of the OMERACT 2014 RA Flare Group Plenary. J Rheumatol 42:2185\u20132189. https:\/\/doi.org\/10.3899\/jrheum.141169","journal-title":"J Rheumatol"},{"key":"4948_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jpainsymman.2020.07.037","volume":"61","author":"M Al Maqbali","year":"2021","unstructured":"Al Maqbali M, Al Sinani M, Al Naamani Z et al (2021) Prevalence of fatigue in patients with cancer: a systematic review and meta-analysis. J Pain Symptom Manag 61:167-189.e14. https:\/\/doi.org\/10.1016\/j.jpainsymman.2020.07.037","journal-title":"J Pain Symptom Manag"},{"key":"4948_CR13","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/0284186X.2018.1557344","volume":"58","author":"S-KH B\u00f8hn","year":"2019","unstructured":"B\u00f8hn S-KH, Thorsen L, Kiserud CE et al (2019) Chronic fatigue and associated factors among long-term survivors of cancers in young adulthood. Acta Oncol 58:753\u2013762. https:\/\/doi.org\/10.1080\/0284186X.2018.1557344","journal-title":"Acta Oncol"},{"key":"4948_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3238\/arztebl.2012.0161","volume":"109","author":"M Horneber","year":"2012","unstructured":"Horneber M, Fischer I, Dimeo F et al (2012) Cancer-related fatigue: epidemiology, pathogenesis, diagnosis, and treatment. Dtsch Arztebl Int 109:161\u2013171. https:\/\/doi.org\/10.3238\/arztebl.2012.0161 (Quiz 172)","journal-title":"Dtsch Arztebl Int"},{"key":"4948_CR15","unstructured":"National Comprehensive Cancer Network (2021) NCCN guidelines for supportive care: cancer-related fatigue. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/fatigue.pdf. Accessed 23 Mar 2021"},{"key":"4948_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s15015-013-0421-2","volume":"16","author":"I Fischer","year":"2013","unstructured":"Fischer I (2013) Diagnostik und differenzialdiagnostik der tumor-fatigue. Im Focus Onkol 16:40\u201344. https:\/\/doi.org\/10.1007\/s15015-013-0421-2","journal-title":"Im Focus Onkol"},{"key":"4948_CR17","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1007\/s00520-018-4318-7","volume":"26","author":"CM O'Higgins","year":"2018","unstructured":"O\u2019Higgins CM, Brady B, O\u2019Connor B et al (2018) The pathophysiology of cancer-related fatigue: current controversies. Support Care Cancer 26:3353\u20133364. https:\/\/doi.org\/10.1007\/s00520-018-4318-7","journal-title":"Support Care Cancer"},{"key":"4948_CR18","first-page":"369","volume":"12","author":"D Cella","year":"1998","unstructured":"Cella D, Peterman A, Passik S et al (1998) Progress toward guidelines for the management of fatigue. Oncology (Williston Park) 12:369\u2013377","journal-title":"Oncology (Williston Park)"},{"key":"4948_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/01.REO.0000000000000124","volume":"36","author":"MI Fisher","year":"2018","unstructured":"Fisher MI, Davies C, Lacy H et al (2018) Oncology section EDGE task force on cancer: measures of cancer-related fatigue\u2014a systematic review. Rehabil Oncol 36:93\u2013105. https:\/\/doi.org\/10.1097\/01.REO.0000000000000124","journal-title":"Rehabil Oncol"},{"key":"4948_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw273","author":"J Weis","year":"2017","unstructured":"Weis J, Tomaszewski KA, Hammerlid E et al (2017) International psychometric validation of an EORTC quality of life module measuring cancer related fatigue (EORTC QLQ-FA12). J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djw273","journal-title":"J Natl Cancer Inst"},{"key":"4948_CR21","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1007\/s11136-018-1918-0","volume":"27","author":"A Hinz","year":"2018","unstructured":"Hinz A, Weis J, Br\u00e4hler E et al (2018) Fatigue in the general population: German normative values of the EORTC QLQ-FA12. Qual Life Res 27:2681\u20132689. https:\/\/doi.org\/10.1007\/s11136-018-1918-0","journal-title":"Qual Life Res"},{"key":"4948_CR22","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/pon.5151","volume":"28","author":"J Weis","year":"2019","unstructured":"Weis J, Wirtz MA, Tomaszewski KA et al (2019) Sensitivity to change of the EORTC quality of life module measuring cancer-related fatigue (EORTC QlQ-FA12): results from the international psychometric validation. Psychooncology 28:1753\u20131761. https:\/\/doi.org\/10.1002\/pon.5151","journal-title":"Psychooncology"},{"key":"4948_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00393-018-0449-y","volume":"78","author":"JG Kuipers","year":"2019","unstructured":"Kuipers JG, Koller M, Zeman F et al (2019) Adh\u00e4renz und gesundheitskommunikationskompetenz in bezug auf das therapieergebnis bei patienten mit rheumatoider arthritis\u202f: auswertungen einer gro\u00dfen beobachtungsstudie (adherence and health literacy as related to outcome of patients treated for rheumatoid arthritis\u202f: analyses of a large-scale observational study). Z Rheumatol 78:74\u201381. https:\/\/doi.org\/10.1007\/s00393-018-0449-y","journal-title":"Z Rheumatol"},{"key":"4948_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van\u2019t Hof MA, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44\u201348. https:\/\/doi.org\/10.1002\/art.1780380107","journal-title":"Arthritis Rheum"},{"key":"4948_CR25","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/ard.2007.084459","volume":"68","author":"G Wells","year":"2009","unstructured":"Wells G, Becker J-C, Teng J et al (2009) Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 68:954\u2013960. https:\/\/doi.org\/10.1136\/ard.2007.084459","journal-title":"Ann Rheum Dis"},{"key":"4948_CR26","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s00296-018-4184-0","volume":"38","author":"L Carpenter","year":"2018","unstructured":"Carpenter L, Norton S, Nikiphorou E et al (2018) Validation of methods for converting the original Disease Activity Score (DAS) to the DAS28. Rheumatol Int 38:2297\u20132305. https:\/\/doi.org\/10.1007\/s00296-018-4184-0","journal-title":"Rheumatol Int"},{"key":"4948_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1026\/0012-1924\/a000205","volume":"64","author":"MA Wirtz","year":"2018","unstructured":"Wirtz MA, Morfeld M, Glaesmer H et al (2018) Normierung des SF-12 Version 2.0 zur Messung der gesundheitsbezogenen Lebensqualit\u00e4t in einer deutschen bev\u00f6lkerungsrepr\u00e4sentativen Stichprobe. Diagnostica 64:215\u2013226. https:\/\/doi.org\/10.1026\/0012-1924\/a000205","journal-title":"Diagnostica"},{"key":"4948_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware","year":"1996","unstructured":"Ware J, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220\u2013233. https:\/\/doi.org\/10.1097\/00005650-199603000-00003","journal-title":"Med Care"},{"key":"4948_CR29","first-page":"97","volume-title":"Clinical diagnosis of mental disorders","author":"JC Nunnally","year":"1979","unstructured":"Nunnally JC (1979) An overview of psychological measurement. In: Wolman BB (ed) Clinical diagnosis of mental disorders. Springer, Boston, pp 97\u2013146"},{"key":"4948_CR30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3758\/BF03203140","volume":"22","author":"RD Hays","year":"1990","unstructured":"Hays RD, Hayashi T (1990) Beyond internal consistency reliability: rationale and user\u2019s guide for multitrait analysis program on the microcomputer. Behav Res Methods Instrum Comput 22:167\u2013175. https:\/\/doi.org\/10.3758\/BF03203140","journal-title":"Behav Res Methods Instrum Comput"},{"key":"4948_CR31","unstructured":"EORTC Quality of Life Unit (2001) EORTC QLQ-C30 Scoring Manual.\nhttps:\/\/www.eortc.org\/app\/uploads\/sites\/2\/2018\/02\/SCmanual.pdf. Accessed 23 Mar 2021"},{"key":"4948_CR32","first-page":"1","volume":"7","author":"U Knief","year":"2018","unstructured":"Knief U, Forstmeier W (2018) Violating the normality assumption may be the lesser of two evils. Behav Res Methods 7:1\u20137","journal-title":"Behav Res Methods"},{"key":"4948_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","volume":"54","author":"R Bender","year":"2001","unstructured":"Bender R, Lange S (2001) Adjusting for multiple testing\u2014when and how? J Clin Epidemiol 54:343\u2013349. https:\/\/doi.org\/10.1016\/S0895-4356(00)00314-0","journal-title":"J Clin Epidemiol"},{"key":"4948_CR34","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.6004\/jnccn.2015.0122","volume":"13","author":"AM Berger","year":"2015","unstructured":"Berger AM, Mooney K, Alvarez-Perez A et al (2015) Cancer-related fatigue, version 2.2015. J Natl Compr Cancer Netw 13:1012\u20131039. https:\/\/doi.org\/10.6004\/jnccn.2015.0122","journal-title":"J Natl Compr Cancer Netw"},{"key":"4948_CR35","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.annonc.2020.02.016","volume":"31","author":"A Fabi","year":"2020","unstructured":"Fabi A, Bhargava R, Fatigoni S et al (2020) Cancer-related fatigue: ESMO clinical practice guidelines for diagnosis and treatment. Ann Oncol 31:713\u2013723. https:\/\/doi.org\/10.1016\/j.annonc.2020.02.016","journal-title":"Ann Oncol"},{"key":"4948_CR36","unstructured":"Deutsche Gesellschaft f\u00fcr Allgemeinmedizin und Familienmedizin e.V (2017) M\u00fcdigkeit: S3-Leitlinie. https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/053-002l_S3_Muedigkeit_2018-06.pdf. Accessed 23 Mar 2021"},{"key":"4948_CR37","unstructured":"Deutsche Gesellschaft f\u00fcr Palliativmedizin (2020) Erweiterte S3-Leitlinie Palliativmedizin f\u00fcr Patienten mit einer nicht-heilbaren Krebserkrankung. https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/128-001OLl_S3_Palliativmedizin_2020-09_02.pdf. Accessed 23 Mar 2021"},{"key":"4948_CR38","unstructured":"Deutsche Krebsgesellschaft e.V. (2014) S3-Leitlinie Psychoonkologische Diagnostik, Beratung und Behandlung von erwachsenen Krebspatienten. https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/032-051OLl_S3_Psychoonkologische_Beratung_Behandlung_2014-01_abgelaufen.pdf. Accessed 23 Mar 2021"},{"key":"4948_CR39","unstructured":"Deutsche Krebsgesellschaft e.V, Deutsche Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe e.V (2020) Interdisziplin\u00e4re S3-Leitlinief\u00fcr die Fr\u00fcherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms. https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/032-045OLl_S3_Mammakarzinom_2020-02.pdf. Accessed 23 Mar 2021"},{"key":"4948_CR40","unstructured":"Leitlinienprogramm Onkologie (2020) S3-Leitlinie Diagnostik, Therapie und Nachsorge des Hodgkin Lymphoms bei erwachsenen Patienten. https:\/\/www.leitlinienprogramm-onkologie.de\/fileadmin\/user_upload\/Downloads\/Leitlinien\/Hodgkin\/Version_3\/LL_Hodgkin_Lymphom_Langversion_3.0.pdf. Accessed 23 Mar 2021"},{"key":"4948_CR41","unstructured":"Leitlinienprogramm Onkologie (2020) Interdisziplin\u00e4re S3-Leitlinief\u00fcr die Fr\u00fcherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms. https:\/\/www.leitlinienprogramm-onkologie.de\/fileadmin\/user_upload\/Downloads\/Leitlinien\/Mammakarzinom_4_0\/Version_4.4\/LL_Mammakarzinom_Langversion_4.04.pdf. Accessed 23 Mar 2021"},{"key":"4948_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ejon.2012.07.002","volume":"17","author":"K Reif","year":"2013","unstructured":"Reif K, de Vries U, Petermann F et al (2013) A patient education program is effective in reducing cancer-related fatigue: a multi-centre randomised two-group waiting-list controlled intervention trial. Eur J Oncol Nurs 17:204\u2013213. https:\/\/doi.org\/10.1016\/j.ejon.2012.07.002","journal-title":"Eur J Oncol Nurs"},{"key":"4948_CR43","doi-asserted-by":"publisher","first-page":"ed81","DOI":"10.3332\/ecancer.2018.ed81","volume":"12","author":"AJ Kuiper","year":"2018","unstructured":"Kuiper AJ, Wolvers MDJ, Vonk D et al (2018) Untire: an all-embracing self-management eHealth program to cope with cancer-related fatigue. Ecancermedicalscience 12:ed81. https:\/\/doi.org\/10.3332\/ecancer.2018.ed81","journal-title":"Ecancermedicalscience"},{"key":"4948_CR44","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s13643-019-1230-2","volume":"8","author":"TK Corbett","year":"2019","unstructured":"Corbett TK, Groarke A, Devane D et al (2019) The effectiveness of psychological interventions for fatigue in cancer survivors: systematic review of randomised controlled trials. Syst Rev 8:324. https:\/\/doi.org\/10.1186\/s13643-019-1230-2","journal-title":"Syst Rev"},{"key":"4948_CR45","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jgo.2016.04.008","volume":"7","author":"KP Loh","year":"2016","unstructured":"Loh KP, Janelsins MC, Mohile SG et al (2016) Chemotherapy-related cognitive impairment in older patients with cancer. J Geriatr Oncol 7:270\u2013280. https:\/\/doi.org\/10.1016\/j.jgo.2016.04.008","journal-title":"J Geriatr Oncol"},{"key":"4948_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1749-6632.2009.04980.x","volume":"1179","author":"OM Wolkowitz","year":"2009","unstructured":"Wolkowitz OM, Burke H, Epel ES et al (2009) Glucocorticoids. Mood, memory, and mechanisms. Ann N Y Acad Sci 1179:19\u201340. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04980.x","journal-title":"Ann N Y Acad Sci"},{"key":"4948_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001084","author":"JE Pope","year":"2020","unstructured":"Pope JE (2020) Management of fatigue in rheumatoid arthritis. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2019-001084","journal-title":"RMD Open"},{"key":"4948_CR48","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1001\/jama.262.7.925","volume":"262","author":"AR Tarlov","year":"1989","unstructured":"Tarlov AR, Ware JE, Greenfield S et al (1989) The medical outcomes study. an application of methods for monitoring the results of medical care. JAMA 262:925\u2013930. https:\/\/doi.org\/10.1001\/jama.262.7.925","journal-title":"JAMA"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04948-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04948-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04948-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T12:04:41Z","timestamp":1643457881000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04948-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["4948"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04948-7","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"25 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JGK reports grants and personal fees from Chugai during the conduct of the study. JGK reports outside the submitted work grants, personal fees and non-financial support from Abbvie, Actelion, Boehringer-Ingelheim, Biogen, Gilead, GSK, Janssen-Cilag, Lilly, MSD, Novartis, Pfizer, Roche, Takeda, UCB. JW received a grant from EORTC Quality of Life Department and from DFaG for the development of EORTC FA12. MK received a grant from DFaG for the conduct of the TRACE study. All other authors have declared no conflicts of interest in the context of this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Study 1, TRACE (Therapie bei Rheumatoider Arthritis Correlate und Einfluss) on adherence with therapy and quality of life of patients with rheumatoid arthritis, was approved by the Ethical Committee of the University of Regensburg (number 13-160-0275). The trial was registered with study database of the German Network of Health Services (VfD_TRACE_14_003438). Study 2, psychometric validation study of the EORTC QLQ-FA12 measuring fatigue in patients with cancer, obtained national and local ethics approvals (reference number of leading Ethics Committee of the University of Freiburg 165\/11). The study was registered with the German Clinical Trial Studies Registry (DRKS00003091). Both studies were conducted in compliance with the Declaration of Helsinki and patients gave their written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}